Standout of the week
Validic
Durham personal-health-data platform
Acquired by ChartSpan.
Validic, a long-running Durham platform for connecting personal health and device data into clinical systems, was acquired by ChartSpan. Terms were not disclosed, and Validic's own site now says it is joining ChartSpan. It is the larger of two Triangle acquisitions this week and a clean outcome for a company that has been part of the Durham digital-health scene for over a decade.
What you should know
Equity Shift completed a strategic asset acquisition of SteadyTrail Technologies, folding employee-ownership workflow features into its BITE platform.
Merakris Therapeutics won a five-year VA Federal Supply Schedule contract for its Dermacyte AC Matrix wound-care product, effective June 2026 through June 2031.
Atsena Therapeutics dosed the first patient in the pivotal ATSN-201 trial for X-linked retinoschisis and reported rapid early enrollment.
Deep dives
Capital
0 rounds
The week's capital events were two acquisitions, covered above and in the quick hits.
Infrastructure
One product launch from an established Durham platform company.